Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Francisco Bolás-Fernández"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 5, p 585 (2024)
Nanomedicine is the application of nanotechnology to achieve innovations in healthcare and involves the engineering of systems at the nanoscale (particle size < 1000 nm) with the aim of improving drug delivery [...]
Externí odkaz:
https://doaj.org/article/10540a1ac58d428a8790477391cfb342
Autor:
Juan F. González, María-Auxiliadora Dea-Ayuela, Lena Huck, José María Orduña, Francisco Bolás-Fernández, Elena de la Cuesta, Nazia Haseen, Ashraf Ali Mohammed, J. Carlos Menéndez
Publikováno v:
Pharmaceuticals, Vol 17, Iss 4, p 487 (2024)
We present a new category of quinoxaline di-N-oxides (QdNOs) containing amino acid side chains with dual antituberculosis and antileishmanial activity. These compounds were synthesized by combining a regioselective 2,5-piperazinedione opening and a B
Externí odkaz:
https://doaj.org/article/81f7d0e10c1b4f46b4287417861449ee
Autor:
Beatriz López-Cauce, Andrés Urquía, Luis Menchén, Kohei Homma, Francisco Bolás-Fernández, Juan J. García-Rodriguez, Marta Puerto
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 150, Iss , Pp 112937- (2022)
AHCC® is a standardized extract of cultured mushroom (Lentinula edodes) mycelia with a wide variety of therapeutic effects including anti-inflammatory, antitumor and antiviral effects. Trichinellosis, a food-borne parasitic zoonosis is caused by the
Externí odkaz:
https://doaj.org/article/6f5289feaca84242ab6ed4e20dc0766a
Autor:
Juan C. Ticona, Pablo Bilbao-Ramos, Ninoska Flores, M. Auxiliadora Dea-Ayuela, Francisco Bolás-Fernández, Ignacio A. Jiménez, Isabel L. Bazzocchi
Publikováno v:
Foods, Vol 9, Iss 9, p 1250 (2020)
The current therapies of leishmaniasis, the second most widespread neglected tropical disease, have limited effectiveness and toxic side effects. In this regard, natural products play an important role in overcoming the current need for new leishmani
Externí odkaz:
https://doaj.org/article/7ae6207b9ed7473c91ccea9a7dd377eb
Publikováno v:
Molecules, Vol 25, Iss 17, p 3918 (2020)
A stronger Th1 (cellular) immune response in canine leishmaniosis (CanL) leads to a better prognosis. Dietary nucleotides plus AHCC® have shown beneficial effects in dogs with clinical leishmaniosis and in clinically healthy Leishmania-infected dogs
Externí odkaz:
https://doaj.org/article/737882e908844d369c50e41b092fc018
Autor:
Pablo Bilbao-Ramos, Dolores R. Serrano, Helga Karina Ruiz Saldaña, Juan J. Torrado, Francisco Bolás-Fernández, María Auxiliadora Dea-Ayuela
Publikováno v:
Molecules, Vol 25, Iss 6, p 1394 (2020)
Leishmaniasis affects around 12 million people worldwide and is estimated to cause the ninth-largest disease burden. There are three main forms of the disease, visceral (VL), cutaneous (CL), and mucocutaneous (MCL), leading to more than one million n
Externí odkaz:
https://doaj.org/article/fefd1fa637234ae0802f754e874b2574
Autor:
Eduardo Sobarzo-Sánchez, Pablo Bilbao-Ramos, Maria Dea-Ayuela, Humberto González-Díaz, Matilde Yañez, Eugenio Uriarte, Lourdes Santana, Victoria Martínez-Sernández, Francisco Bolás-Fernández, Florencio M Ubeira
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77560 (2013)
Leishmaniasis is a growing health problem worldwide. As there are certain drawbacks with the drugs currently used to treat human leishmaniasis and resistance to these drugs is emerging, there is a need to develop novel antileishmanial compounds, amon
Externí odkaz:
https://doaj.org/article/42d02becc0354f0b84780b4c633d05c4
Autor:
Raquel Fernández-García, Juan C. Muñoz-García, Matthew Wallace, Laszlo Fabian, Elena González-Burgos, M. Pilar Gómez-Serranillos, Rafaela Raposo, Francisco Bolás-Fernández, M. Paloma Ballesteros, Anne Marie Healy, Yaroslav Z. Khimyak, Dolores R. Serrano
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 341
Antifungal drugs such as amphotericin B (AmB) interact with lipids and phospholipids located on fungal cell membranes to disrupt them and create pores, leading to cell apoptosis and therefore efficacy. At the same time, the interaction can also take
Autor:
María Auxiliadora Dea-Ayuela, Luiz Felipe Domingues Passero, Larry Sttats, Márcia Dalastra Laurenti, Dolores R. Serrano, Francisco Bolás-Fernández, Jéssica Adriana Jesus, Aikaterini Lalatsa, Raquel Fernández-García, Maria Paloma Ballesteros
Publikováno v:
The 1st International Electronic Conference on Pharmaceutics.
Amphotericin B (AmB) is a high-molecular weight poorly soluble drug with a high efficacy in the treatment of infectious caused by Leishmania spp. parasites, which possesses a very low topical bioavailability. Transferosomes (TFs) are ultradeformable
Autor:
Jéssica Adriana Jesus, María Auxiliadora Dea-Ayuela, Aikaterini Lalatsa, Francisco Bolás-Fernández, Rúben Simão, Márcia Dalastra Laurenti, Larry Statts, Dolores R. Serrano, Maria Paloma Ballesteros, Raquel Fernández-García, Liliana Bautista, Luiz Felipe Domingues Passero
Publikováno v:
CEU Repositorio Institucional
Fundación Universitaria San Pablo CEU (FUSPCEU)
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Fundación Universitaria San Pablo CEU (FUSPCEU)
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Este artículo se encuentra disponible en la siguiente URL: https://pubs.acs.org/doi/10.1021/acsinfecdis.0c00293 Nota de Fondos: Esta versión preprint del artículo se encuentra a texto completo en el CEU Repositorio Institucional. En esta investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c5c0641549fb6ab52e376e78f58738
https://strathprints.strath.ac.uk/81138/1/Fernandez_Garcia_etal_ACS_ID_2020_Ultradeformable_lipid_vesicles_localize_amphotericin_B_in_the_dermis.pdf
https://strathprints.strath.ac.uk/81138/1/Fernandez_Garcia_etal_ACS_ID_2020_Ultradeformable_lipid_vesicles_localize_amphotericin_B_in_the_dermis.pdf